(Reuters) Allergan Plc (AGN.N) said on Thursday former Abbott Laboratories (ABT.N) executive Thomas Freyman will join its board, a week after two of its shareholders criticized the drugmaker’s acquisition strategy and board composition.
Allergan appoints former Abbott executive to its board
This entry was posted in Syndicated. Bookmark the permalink.
